SAB Biotherapeutics Inc

SABS NASDAQ Santé & Biotech États-Unis US78397T1034
3.35 $
1.21 %

SAB Biothapeutics Inc est spécialisée dans le développement de thérapies immunitaires polyclonales utilisant des solutions biopharmaceutiques avancées.

Performance & Momentum

6 Months 6.69 %
1 Year 78.19 %
3 Years 62.98 %
5 Years 96.63 %

Similar stocks to SAB Biotherapeutics Inc

Anantys Community

Be the first to share your analysis on SAB Biotherapeutics Inc.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases